Navamedic ASA: Invitation to 2022 third quarter presentation

Publisert: 25.10.2022

Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation

Publisert: 20.10.2022

Navamedic ASA: Q2 and first half 2022 financial results

Publisert: 12.08.2022

Navamedic ASA: Invitation to 2022 second quarter presentation

Publisert: 09.08.2022

Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®

Publisert: 04.08.2022

Navamedic ASA: Trading Update

Publisert: 04.07.2022